MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$154,651K
EPS
-$2.29
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
132,009
General and administrative
38,595
Total operating expenses
170,604
Loss from operations
-170,604
Interest income, net
15,953
Other income
0
Total other income, net
15,953
Net loss
-154,651
Basic EPS
-2.29
Diluted EPS
-2.29
Basic Average Shares
67,656,355
Diluted Average Shares
67,656,355
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income, net$15,953K Net loss-$154,651K Total other income,net$15,953K Loss from operations-$170,604K Total operatingexpenses$170,604K Research and development$132,009K General andadministrative$38,595K

Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. (MLYS)